The NPM1 mutant defines AML irrespective of blast count

被引:10
|
作者
Falini, Brunangelo [1 ,2 ]
Martelli, Maria Paola [1 ,2 ]
Brunetti, Lorenzo [3 ,4 ]
Gjertsen, Bjorn T. [5 ]
Andresen, Vibeke [5 ]
机构
[1] Univ Perugia, Inst Hematol, Ctr Hemato Oncol Res CREO, Perugia, Italy
[2] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Sci, Bergen, Norway
[3] Univ Politecn Marche, Dept Clin & Mol Sci, Ancona, Italy
[4] Azienda Ospedaliero Univ Marche, Inst Hematol, Ancona, Italy
[5] Santa Maria Misericordia Hosp, Perugia, Italy
关键词
NUCLEOPHOSMIN; LEUKEMIA;
D O I
10.1002/ajh.26946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E187 / E189
页数:3
相关论文
共 50 条
  • [21] Recent advances in AML with mutated NPM1
    Ishikawa, Yuichi
    Ushijima, Yoko
    Kiyoi, Hitoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (05) : 556 - 565
  • [22] The antagonistic duality of NPM1 mutations in AML
    Khan, Irum
    Gartel, Andrei L.
    BLOOD ADVANCES, 2022, 6 (13) : 4028 - 4030
  • [23] Recent advances in AML with mutated NPM1
    Ishikawa, Yuichi
    Ushijima, Yoko
    Kiyoi, Hitoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024,
  • [24] Selective silencing of the NPM1 mutant protein and apoptosis induction upon ATRA in vitro treatment of AML cells carrying NPM1 mutations.
    Martelli, M. P.
    Pettirossi, V.
    Manes, N.
    Liso, A.
    Cecchetti, F.
    De Marco, M. F.
    Bigerna, B.
    Pucciarini, A.
    Nicoletti, I.
    Martelli, M. F.
    Falini, B.
    BLOOD, 2007, 110 (11) : 266A - 266A
  • [25] THE NPM1 MUTANT IS EXPRESSED IN CAJAL BODIES AND LOST DURING DIFFERENTIATION IMPLICATION FOR THE PATHOGENESIS OF NPM1-MUTATED AML
    Falini, B.
    Marafioti, T.
    Marra, A.
    Facchetti, F.
    Bigerna, B.
    Sorcini, D.
    Perriello, V.
    Tiacci, E.
    Sportoletti, P.
    Martelli, M. P.
    Gjertsen, B. T.
    Andresen, V.
    HAEMATOLOGICA, 2024, 109 : 30 - 31
  • [26] Biological and clinical consequences of NPM1 mutations in AML
    Heath, E. M.
    Chan, S. M.
    Minden, M. D.
    Murphy, T.
    Shlush, L. I.
    Schimmer, A. D.
    LEUKEMIA, 2017, 31 (04) : 798 - 807
  • [27] Unexpected phenotype of a typical NPM1 mutant
    Pianta, Annalisa
    Fabbro, Dora
    Damiani, Daniela
    Tiribelli, Mario
    Fanin, Renato
    Franzoni, Alessandra
    Romanello, Milena
    Tell, Gianluca
    Damante, Giuseppe
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (05) : 760 - 763
  • [28] Efficacy of Novel Non-Chemotherapy Combinations Against AML Cells with Mutant NPM1
    Mill, Christopher Peter
    Fiskus, Warren C.
    Davis, John A.
    Das, Kaberi
    Birdwell, Christine E.
    Kadia, Tapan M.
    Sasaki, Koji
    Takahashi, Koichi
    DiNardo, Courtney D.
    Loghavi, Sanam
    Daver, Naval
    Bhalla, Kapil N.
    BLOOD, 2022, 140 : 5860 - 5861
  • [29] Biological and clinical consequences of NPM1 mutations in AML
    E M Heath
    S M Chan
    M D Minden
    T Murphy
    L I Shlush
    A D Schimmer
    Leukemia, 2017, 31 : 798 - 807
  • [30] INTERACTION OF ELF-4 AND NPM1 IN AML
    Miyazaki, Y.
    Ando, K.
    Tsushima, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 24 - 24